Literature DB >> 17728367

Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.

M B Urowitz1, D Gladman, D Ibañez, P Fortin, J Sanchez-Guerrero, S Bae, A Clarke, S Bernatsky, C Gordon, J Hanly, D Wallace, D Isenberg, E Ginzler, J Merrill, G Alarcon, K Steinsson, M Petri, M A Dooley, I Bruce, S Manzi, M Khamashta, R Ramsey-Goldman, A Zoma, G Sturfelt, O Nived, P Maddison, J Font, R van Vollenhoven, C Aranow, K Kalunian, T Stoll, J Buyon.   

Abstract

Systemic Lupus International Collaborating Clinics (SLICC) comprises 27 centres from 11 countries. An inception cohort of 918 SLE patients has been assembled according to a standardized protocol between 2000 and 2006. Clinical features, classic coronary artery disease (CAD) risk factors, as well as other potential risk factors were collected. Of the 918 patients 89% were females, and of multi racial origin. Less than half the patients were living in a permanent relationship, 58% had post secondary education and 51% were employed. Eight percent had family history of SLE. At enrolment, with at mean age of diagnosis of 34.5 years, a significant number of patients already had CAD risk factors, such as hypertension (33%) and hypercholesterolemia (36%). Only 15% of the patients were postmenopausal, 16% were current smokers and 3.6% had diabetes at entry to the SLICC-RAS (Registry for Atherosclerosis). A number of patients in this multi-racial, multi-ethnic inception cohort of lupus patients have classic CAD risk factors within a mean of 5.4 months from diagnosis. This cohort will be increased to 1500 patients to be followed yearly for 10 years. This will provide a unique opportunity to evaluate risk factors for accelerated atherosclerosis in SLE.

Entities:  

Mesh:

Year:  2007        PMID: 17728367     DOI: 10.1177/0961203307081113

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  32 in total

1.  Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.

Authors:  M B Urowitz; D Gladman; D Ibañez; S C Bae; J Sanchez-Guerrero; C Gordon; A Clarke; S Bernatsky; P R Fortin; J G Hanly; D J Wallace; D Isenberg; A Rahman; G S Alarcón; J T Merrill; E Ginzler; M Khamashta; O Nived; G Sturfelt; I N Bruce; K Steinsson; S Manzi; R Ramsey-Goldman; M A Dooley; A Zoma; K Kalunian; M Ramos; R F Van Vollenhoven; C Aranow; T Stoll; M Petri; P Maddison
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

Review 2.  Pathogenesis and treatment of atherosclerosis in lupus.

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

3.  Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study.

Authors:  Mala S Kaul; Sunil V Rao; Linda K Shaw; Emily Honeycutt; Stacy P Ardoin; E William St Clair
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

Review 4.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

5.  Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography.

Authors:  C A Roldan; J Joson; C R Qualls; J Sharrar; W L Sibbitt
Journal:  Lupus       Date:  2010-09-02       Impact factor: 2.911

6.  Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic.

Authors:  Antonio Naranjo; Ana Bilbao; Celia Erausquin; Soledad Ojeda; Félix M Francisco; Iñigo Rúa-Figueroa; Carlos Rodríguez-Lozano
Journal:  Rheumatol Int       Date:  2013-09-05       Impact factor: 2.631

Review 7.  Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery.

Authors:  Susan M Goodman; C Ronald Mackenzie
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

Review 8.  Atherosclerosis in systemic lupus erythematosus.

Authors:  George Stojan; Michelle Petri
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

9.  The SLICC inception cohort for atherosclerosis.

Authors:  Murray B Urowitz; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

10.  IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Authors:  Colin Edgerton; José C Crispín; Chantal M Moratz; Estelle Bettelli; Mohamed Oukka; Milomir Simovic; Athina Zacharia; Ryan Egan; Jie Chen; Jurandir J Dalle Lucca; Yuang-Taung Juang; George C Tsokos
Journal:  Clin Immunol       Date:  2008-12-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.